INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2025

Beni-koji (red yeast rice) tablet use was linked to Fanconi syndrome and persistent kidney dysfunction in a nationwide Japanese survey.

A two-phase nationwide survey of Japanese nephrologists investigated 192 patients with kidney injury associated with specific Beni-koji tablets. At presentation, 94.1% had an eGFR below 60 ml/min/1.73m2, alongside features of Fanconi syndrome such as hypokalemia, hypophosphatemia, hypouricemia, glycosuria, and metabolic acidosis. Kidney biopsies showed predominant tubulointerstitial changes, including tubulointerstitial nephritis in 50% and tubular necrosis in 32%. Following product discontinuation and treatment, Fanconi syndrome parameters improved significantly, but 87% of patients still had an eGFR under 60 ml/min/1.73m2 at the last observation.

Shows an association, not proof of cause and effect.

Study type
Two-phase nationwide questionnaire survey
Who was studied
192 patients with kidney injury associated with Beni-koji tablets in Japan
What was measured
Clinical, laboratory, and pathological features, and eGFR trajectories

THE PAPER

A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan.

Shinzawa M, Matsui I, Doi Y, Matsumoto A, Takahashi A, Nangaku M, Isaka Y, Collaborators. Kidney Int, 2025.

PubMed 39708997 ↗DOI 10.1016/j.kint.2024.11.027 ↗

Kidney healthFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.